Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma

Table 1 Clinical parameters of suspected subjects with elevated miRNA-106b levels

Clinical parameter	n (%)	miRNA-106b level	t value	P value
History of hepatitis
Have	20 (57.14)	4.62 ± 0.91	0.532	0.598
None	15 (42.86)	4.45 ± 0.97
Long-term drinking history
Have	24 (68.57)	4.72 ± 0.92	1.378	0.177
None	11 (31.43)	4.29 ± 0.69
Obesity
Have	16 (45.71)	4.62 ± 0.90	0.986	0.331
None	19 (54.29)	4.35 ± 0.72
Liver cancer stage
I/II	33 (94.26)	4.64 ± 0.86	-4.200	0.000
III/IV	2 (5.74)	7.23 ± 0.02